Else Nutrition Announces CSE Conditional Approval

June 29, 2026

Else Nutrition Holdings Inc. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) has received conditional approval to list its common shares on the Canadian Securities Exchange (CSE). The company is currently working to secure additional funding of US$310,000 from Lind Global Fund III LP to facilitate this listing.

The listing on the CSE is still subject to approval from the exchange and the satisfaction of standard listing conditions. There is no guarantee that the listing will be finalized.

As part of the process to list on the CSE, Else Nutrition will conduct a share consolidation of 10 existing shares for each 1 new share. Additionally, the company plans to settle $207,000 of debt by issuing common shares at a post-consolidated price of $0.15 per share.

Else Nutrition aims for trading to commence on the CSE by July 7, provided that it completes final filings with the CSE, secures the financing, settles the debt, and carries out the share consolidation.

Else Nutrition Holdings Inc. focuses on developing innovative, clean, and plant-based food and nutrition products for multiple age groups, including infants and adults. The company has garnered recognition for its plant-based formula and has achieved significant sales growth since launching its products.

This announcement includes forward-looking statements regarding the company's plans and expectations for the CSE listing and potential outcomes. Actual results may differ from these statements, and readers are advised not to place undue reliance on them.

Disclaimer: This press release has been distributed on behalf of the issuing organization. PR Gun acts solely as a distribution platform and has not independently verified the accuracy, completeness, or validity of the statements contained herein.